[HTML][HTML] Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
A large body of evidence indicates the existence of a complex pathophysiological
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …
[HTML][HTML] Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related
deaths in the world. More than half of patients with HCC present with advanced stage, and …
deaths in the world. More than half of patients with HCC present with advanced stage, and …
[HTML][HTML] Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
H Yan, A Jiang, Y Huang, J Zhang, W Yang… - Frontiers in …, 2023 - frontiersin.org
Introduction Hypoxia is associated with unfavorable prognoses in melanoma patients, and
the limited response rates of patients to PD-1/PD-L1 blockade could be attributed to the …
the limited response rates of patients to PD-1/PD-L1 blockade could be attributed to the …
“Reinforcement” by tumor microenvironment: the seventh “R” of radiobiology
F Taghizadeh-Hesary - International Journal of Radiation Oncology …, 2024 - redjournal.org
Radiation therapy is a highly effective method for inhibiting tumor growth and is widely used
in clinical settings. 1 It damages the vital biomolecules (especially DNA) of cancer cells and …
in clinical settings. 1 It damages the vital biomolecules (especially DNA) of cancer cells and …
[HTML][HTML] Molecular mechanism of specific HLA-A mRNA recognition by the RNA-binding-protein hMEX3B to promote tumor immune escape
K Yang, G Chen, F Yu, X Fang, J Zhang… - Communications …, 2024 - nature.com
Immunotherapy, including immune checkpoint inhibitors and adoptive cell transfer, has
obtained great progress, but their efficiencies vary among patients due to the genetic and …
obtained great progress, but their efficiencies vary among patients due to the genetic and …
[HTML][HTML] Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX
J Chang, C Xin, Y Wang, Y Wang - Oncology Letters, 2023 - spandidos-publications.com
Calcium/calmodulin‑dependent protein kinase kinase 2 (CaMKK2) and mitochondrial
sodium/calcium exchanger protein (NCLX) are key regulatory factors in calcium …
sodium/calcium exchanger protein (NCLX) are key regulatory factors in calcium …
[HTML][HTML] Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity
R Torcasio, ME Gallo Cantafio, C Veneziano… - Journal of Translational …, 2024 - Springer
Background Mitochondrial alterations, often dependent on unbalanced mitochondrial
dynamics, feature in the pathobiology of human cancers, including multiple myeloma (MM) …
dynamics, feature in the pathobiology of human cancers, including multiple myeloma (MM) …
[HTML][HTML] Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Y Feng, Z Yang, J Wang, H Zhao - Cell Communication and Signaling, 2024 - Springer
Copper plays vital roles in numerous cellular processes and its imbalance can lead to
oxidative stress and dysfunction. Recent research has unveiled a unique form of copper …
oxidative stress and dysfunction. Recent research has unveiled a unique form of copper …
[HTML][HTML] ROS-producing nanomaterial engineered from Cu(I) complexes with P2N2-ligands for cancer cells treating
BA Faizullin, IR Dayanova, AV Kurenkov… - Discover Nano, 2023 - Springer
The work presents core–shell nanoparticles (NPs) built from the novel Cu (I) complexes with
cyclic P2N2-ligands (1, 5-diaza-3, 7-diphosphacyclooctanes) that can visualize their entry …
cyclic P2N2-ligands (1, 5-diaza-3, 7-diphosphacyclooctanes) that can visualize their entry …
Deciphering and overcoming Anti-PD-1 resistance in Melanoma: A comprehensive review of Mechanisms, biomarker Developments, and therapeutic strategies
R Wang, Y Chen, Y Xie, X Ma, Y Liu - International Immunopharmacology, 2024 - Elsevier
Worldwide, tens of thousands of people die from melanoma each year, making it the most
frequently fatal form of cutaneous cancer. Immunotherapeutic advancements, particularly …
frequently fatal form of cutaneous cancer. Immunotherapeutic advancements, particularly …